COVID-19: Covaxin 1st Indian vax to get peer-reviewed data
Virendra Pandit Mumbai: Covaxin, India’s first indigenous vaccine against the global pandemic of COVID-19, has shown enhanced immune response without any serious side-effects in the volunteers enrolled for the Phase 1 trials, a study in the prestigious medical publication, The Lancet Infectious Disease Journal, has said. Covaxin, developed by Bharat Biotech International Ltd (BBIL) in […]


